Senores Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals Limited has submitted a disclosure to the stock exchange as required under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation pertains to disclosures related to encumbered (pledged) shares held by promoters of the company. No specific details on pledge levels, changes, or promoter shareholding figures were provided in the announcement headline itself. Investors would need to review the actual disclosure document to understand the exact nature of the encumbrance or any change in pledged holdings.
For shareholders, this is a routine regulatory compliance filing and on its own does not indicate any major event. However, investors should check the attached disclosure to see whether promoter pledged shares have increased, decreased, or remained unchanged, as high pledge levels can be a risk factor.